LGI1: From zebrafish to human epilepsy

Progress in Brain Research

Volumn 213, Issue C, 2014, Pages 159-179

  Cowell, John K ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

ADAM22; ADAM23; Cortical dysplasia; Epilepsy; LGI1; Limbic encephalitis; Seizure; Synapse function; Zebrafish

Indexed keywords

AUTOANTIBODY; LGI1 PROTEIN, HUMAN; PROTEIN;

ANIMAL BEHAVIOR; ARTICLE; BRAIN DEVELOPMENT; BRAIN FUNCTION; EPILEPSY; EPILEPTOGENESIS; EXPERIMENTAL SEIZURE; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; LGI1 GENE; MAMMAL; MOLECULAR GENETICS; MOUSE MODEL; MUTANT; NONHUMAN; PARANEOPLASTIC NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SYNAPTIC TRANSMISSION; ZEBRA FISH; ANIMAL; GENETICS; MUTATION;

ANIMALS; EPILEPSY; HUMANS; MUTATION; PROTEINS; ZEBRAFISH;

EID: 84926303571     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-63326-2.00009-0     Document Type: Chapter

References (89)

1. Baraban S.C., Taylor M.R., Castro P.A., Baier H. Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 2005, 131:759-768.
2. Baraban S.C., Dinday M.T., Castro P.A., Chege S., Guyenet S., Taylor M.R. A large-scale mutagenesis screen to identify seizure-resistant zebrafish. Epilepsia 2007, 48:1151-1157.
3. Barkovich A.J., Kuzniecky R.I., Jackson G.D., Guerrini R., Dobyns W.B. A developmental and genetic classification for malformations of cortical development. Neurology 2005, 65:1873-1887.
4. Baulac S., Ishida S., Mashimo T., Boillot M., Fumoto N., Kuwamura M., Ohno Y., Takizawa A., Aoto T., Ueda M., Ikeda A., LeGuern E., Takahashi R., Serikawa T. A rat model for LGI1-related epilepsies. Hum. Mol. Genet. 2012, 21:3546-3557.
5. Berghmans S., Hunt J., Roach A., Goldsmith P. Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants. Epilepsy Res. 2007, 75:18-28.
6. Bisulli F., Tinuper P., Scudellaro E., Naldi I., Bagattin A., Avoni P., Michelucci R., Nobile C. A de novo LGI1 mutation in sporadic partial epilepsy with auditory features. Ann. Neurol. 2004, 56:455-456.
7. Blümcke I., Thom M., Aronica E., Armstrong D.D., Vinters H.V., Palmini A., Jacques T.S., Avanzini G., Barkovich A.J., Battaglia G., Becker A., Cepeda C., Cendes F., Colombo N., Crino P., Cross J.L., Delalande O., Dubeau F., Duncan J., Guerrini R., Kahane P., Mathern G., Najm I., Özkara Ç., Raybaud C., Represa A., Roper S.N., Salamon N., Schulze-Bonhage A., Tassi L., Vezzani A., Spreafico R. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia 2011, 52:158-174.
8. Bremingham J.R., Shearin H., Pennington J., O'Moore J., Jaegle M., Driegen S., van Zon A., Darbas A., Ozkaynak E., Ryu E.J., Milbrandt J., Meijer D. The claw paw mutation reveals a role for Lgi4 in peripheral nerve development. Nat. Neurosci. 2006, 9:76-84.
9. Brodtkorb E., Nakken K.O., Steinlein O.K. No evidence for a seriously increased malignancy risk in LGI1-caused epilepsy. Epilepsy Res. 2003, 56:205-208.
10. Buchanan S.G., Gay N.J. Structural and functional diversity in the leucine-rich repeat family of proteins. Prog. Biophys. Mol. Biol. 1996, 65:1-44.
11. Buoni S., Zannolli R., Miracco C., Macucci F., Hayek J., Burroni L., di Pietro G., Sardo L., Mussa F., Giordano F., Genitori L. Focal cortical dysplasia type 1b as a cause of severe epilepsy with multiple independent spike foci. Brain Dev. 2008, 30:53-58.
12. Caviness V.S., Bhide P.G., Nowakowski R.S. Histogenetic process leading to the laminated neocortex: migration is only a part of the story. Dev. Neurosci. 2008, 30:82-95.
13. Chabrol E., Navarro V., Provenzano G., Cohen I., Dinocourt C., Rivaud-Péchoux S., Fricker D., Baulac M., Miles R., LeGuern E., Baulac S. Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1-deficient mice. Brain 2010, 133:2749-2762.
14. Chernova O., Somerville R.P.T., Cowell J.K. A novel gene, LGI1, from region 10q24, is rearranged and downregulated in malignant brain tumors. Oncogene 1998, 17:2873-2881.
15. Cowell J.K., Head K., Kunapuli P., Vaughan M., Karasik E., Foster B. Inactivation of LGI1 expression accompanies early stage hyperplasia of prostate epithelium in the TRAMP murine model of prostate cancer. Exp. Mol. Pathol. 2010, 88:77-81.
16. Dalmau J., Tüzün E., Wu H.Y., Masjuan J., Rossi J.E., Voloschin A., Baehring J.M., Shimazaki H., Koide R., King D., Mason W., Sansing L.H., Dichter M.A., Rosenfeld M.R., Lynch D.R. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann. Neurol. 2007, 61:25-36.
17. Di Bonaventura C., Carni M., Diani E., Fattouch J., Vaudano E.A., Egeo G., Pantano P., Maraviglia B., Bozzao L., Manfredi M., Prencipe M., Giallonardo T.A., Nobile C. Drug resistant ADLTE and recurrent partial status epilepticus with dysphasic features in a family with a novel LGI1mutation: electroclinical, genetic and EEG/fMRI findings. Epilepsia 2009, 50:2481-2486.
18. Dierssen M., Ramakers G.J. Dendritic pathology in mental retardation: from molecular genetics to neurobiology. Genes Brain Behav. 2006, 5:48-60.
19. Dragunow M., Robertson H.A. Seizure-inducible c-fos protein(s) in mammalian neurons. Trends Pharmacol. Sci. 1988, 9:5-6.
20. Edwards D.R., Handsley M.M., Pennington C.J. The ADAM metalloproteinases. Mol. Aspects Med. 2008, 29:258-289.
21. Fairen A., Cobas A., Fonseca M. Times of generation of glutamic acid decarboxylase immunoreactive neurons in mouse somatosensory cortex. J. Comp. Neurol. 1986, 251:67-83.
22. Fukata Y., Adesnik H., Iwanaga T., Bredt D.S., Nicoll R.A., Fukata M. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 2006, 313:1792-1795.
23. Fukata Y., Lovero K.L., Iwanaga T., Watanabe A., Yokoi N., Tabuchi K., Shigemoto R., Nicolf R.A., Fukata M. Disruption of Lgi1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3799-3804.
24. Gabellini N., Masola V., Quartesan S., Oselladore B., Nobile C., Michelucci R., Curtarello M., Parolin C., Palú G. Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells. J. Cell. Physiol. 2006, 207:711-721.
25. Gong S., Yang X.W., Li C., Heintz N. Highly efficient modification of bacterial artificial chromosomes (BACs) using novel shuttle vectors containing the R6Kgamma origin of replication. Genome Res. 2002, 12:1992-1998.
26. Greenberg D.A., Pal D.K. The state of the art in the genetic analysis of the epilepsies. Curr. Neurol. Neurosci. Rep. 2007, 7:320-328.
27. Gu W., Wevers A., Schroder H., Grzeschik K.-H., Derst C., Brodtkorb E., de Vos R., Steinlein O.K. The LGI1 gene involved in lateral temporal lobe epilepsy belongs to a new subfamily of leucine-rich proteins. FEBS Lett. 2002, 519:71-76.
28. Gu W., Brodtkorb E., Piepoli T., Finocchiaro G., Steinlein O.K. LGI1: a gene involved in epileptogenesis and glioma progression?. Neurogenetics 2005, 6:59-66.
29. Gu W., Gibert Y., Wirth T., Elischer A., Bloch W., Meyer A., Steinlein O.K., Begemann G. Using gene-history and expression analyses to assess the involvement of LGI genes in human disorders. Mol. Biol. Evol. 2005, 22:2209-2216.
30. Head K., Gong S., Joseph S., Wang C., Burkhardt T., Rossi M.R., LaDuca J., Matsui S.I., Vaughan M., Hicks D.G., Heintz N., Cowell J.K. Defining the expression pattern of the Lgi1 gene in BAC transgenic mice. Mamm. Genome 2007, 18:328-337.
31. Hernández-Miranda L.R., Parnavelas J.G., Chiara F. Molecules and mechanisms involved in the generation and migration of cortical interneurons. ASN Neuro 2010, 2:e00031.
32. Hewapathirane D.S., Dunfield D., Yen W., Chen S., Haas K. In vivo imaging of seizure activity in a novel developmental seizure model. Exp. Neurol. 2008, 211:480-488.
33. Hirose S., Mitsudome A., Okada M., Kaneko S., Epilepsy Genetic Study Group, Japan Genetics of idiopathic epilepsies. Epilepsia 2005, 46(Suppl. 1):38-43.
34. Ho Y.Y., Ionita-Laza I., Ottman R. Domain-dependent clustering and genotype-phenotype analysis of LGI1 mutations in ADPEAF. Neurology 2012, 78:563-568.
35. Kalachikov S., Evgrafov O., Ross B., Winawer M., Barker-Cummings C., Martinelli Boneschi F., Choi C., Morozov P., Das K., Teplitskaya E., Yu A., Cayanis E., Penchaszadeh G., Kottmann A.H., Pedley T.A., Hauser W.A., Ottman R., Gilliam T.C. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat. Genet. 2002, 30:335-341.
36. Kegel L., Aunin E., Meijer D., Bermingham J.R. LGI proteins in the nervous system. ASN Neuro 2013, 5:167-181.
37. Kobau R., Zahran H., Thurman D.J., Zack M.M., Henry T.R., Schachter S.C., Price P.H., Centers for Disease Control and Prevention (CDC) Epilepsy surveillance among adults-19 States. Behavioral Risk Factor Surveillance System, 2005. MMWR Surveill. Summ. 2008, 57:1-20.
38. Kobayashi E., Santos N.F., Torres F.R., Secolin R., Sardinha L.A., Lopez-Cendes I., Cendes F. Magnetic resonance imaging abnormalities in familial temporal lobe epilepsy with auditory auras. Arch. Neurol. 2003, 60:1546-1551.
39. Kobe B., Kajava A.V. The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 2001, 11:725-732.
40. Krex D., Hauses M., Appelt H., Mohr B., Ehninger G., Schackert H.K., Schackert G. Physical and functional characterization of the human LGI1 gene and its possible role in glioma development. Acta Neuropathol. 2002, 103:255-266.
41. Kunapuli P., Chitta K., Cowell J.K. Suppression of the cell proliferation and invasion phenotypes in glioma cells by the LGI1 gene. Oncogene 2003, 22:3985-3991.
42. Kunapuli P., Chitta K.S., Hawthorn L., Cowell J.K. LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the Erk1/2 pathway. J. Biol. Chem. 2004, 279:23151-23157.
43. Kunapuli P., Jang G., Kazim L., Cowell J.K. Mass spectrometry identifies LGI1-interacting proteins that are involved in synaptic vesicle function in the human brain. J. Mol. Neurosci. 2009, 39:137-143.
44. Kunapuli P., Lo K., Hawthorn L., Cowell J.K. Reexpression of LGI1 in glioma cells results in dysregulation of genes implicated in the canonical axon guidance pathway. Genomics 2010, 95:93-100.
45. Kusuzawa S., Honda T., Fukata Y., Fukata M., Kanatani S., Tanaka D.H., Nakajima K. Leucine-rich glioma inactivated 1 (Lgi1), an epilepsy-related secreted protein, has a nuclear localization signal and localizes to both the cytoplasm and the nucleus of the caudal ganglionic eminence neurons. Eur. J. Neurosci. 2012, 36:2284-2292.
46. Lai M., Hughes E.G., Peng X., Zhou L., Gleichman A.J., Shu H., Matà S., Kremens D., Vitaliani R., Geschwind M.D., Bataller L., Kalb R.G., Davis R., Graus F., Lynch D.R., Balice-Gordon R., Dalmau J. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann. Neurol. 2009, 65:424-434.
47. Lai M., Huijbers M.G., Lancaster E., Graus F., Bataller L., Balice-Gordon R., Cowell J.K., Dalmau J. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010, 9:776-785.
48. Lancaster E., Lai M., Peng X., Hughes E., Constantinescu R., Raizer J., Friedman D., Skeen M.B., Grisold W., Kimura A., Ohta K., Iizuka T., Guzman M., Graus F., Moss S.J., Balice-Gordon R., Dalmau J. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010, 9:67-76.
49. Leonardi E., Andreazza S., Vanin S., Busolin G., Nobile C., Tosatto S.C. A computational model of the LGI1 protein suggests a common binding site for ADAM proteins. PLoS One 2011, 6:e18142.
50. McMillan D.R., White P.C. Loss of the transmembrane and cytoplasmic domains of the very large G-protein-coupled receptor-1 (VLGR1 or Mass1) causes audiogenic seizures in mice. Mol. Cell. Neurosci. 2004, 26:322-329.
51. Michelucci R., Poza J.J., Sofia V., de Feo M.R., Binelli S., Bisulli F., Scudellaro E., Simionati B., Zimbello R., D'Orsi G., Passarelli D., Avoni P., Avanzini G., Tinuper P., Biondi R., Valle G., Mautner V.F., Stephani U., Tassinari C.A., Moschonas N.K., Siebert R., Lopez de Munain A., Perez-Tur J., Nobile C. Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European families. Epilepsy 2003, 44:1289-1297.
52. Michelucci R., Mecarelli O., Bovo G., Bisulli F., Testoni S., Striano P., Striano S., Tinuper P., Nobile C. A de novo LGI1 mutation causing idiopathic partial epilepsy with telephone-induced seizures. Neurology 2007, 68:2150-2151.
53. Michelucci R., Pasini E., Malacrida S., Striano P., Bonaventura C.D., Pulitano P., Bisulli F., Egeo G., Santulli L., Sofia V., Gambardella A., Elia M., de Falco A., Neve Al, Banfi P., Coppola G., Avoni P., Binelli S., Boniver C., Pisano T., Marchini M., Dazzo E., Fanciulli M., Bartolini Y., Riguzzi P., Volpi L., de Falco F.A., Giallonardo A.T., Mecarelli O., Striano S., Tinuper P., Nobile C. Low penetrance of autosomal dominant lateral temporal epilepsy in Italian families without LGI1 mutations. Epilepsia 2013, 54:1288-1297.
54. Mitchell K.J., Pinsonm K.I., Kelly O.G., Brennan J., Zupicich J., Scherz P., Leighton P.A., Goodrich L.V., Lu X., Avery B.J., Tate P., Dill K., Pangilinan E., Wakenight P., Tessier-Lavigne M., Skarnes W.C. Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat. Genet. 2001, 28:241-249.
55. Morante-Redolat J.M., Gorostidi-Pagola A., Piquer-Sirerol S., Saenz A., Poza J.J., Galan J., Gesk S., Sarafidou T., Mautner V.F., Binelli S., Staub E., Hinzmann B., French L., Prud'homme J.F., Passarelli D., Scannapieco P., Tassinari C.A., Avanzini G., Marti-Masso J.F., Kluwe L., Deloukas P., Moschonas N.K., Michelucci R., Siebert R., Nobile C., Perez-Tur J., Lopez D.M. Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum. Mol. Genet. 2002, 11:1119-1128.
56. Morgan J.I., Cohen D.R., Hempstead J.L., Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 1987, 10:192-197.
57. Nobile C., Michelucci R., Andreazza S., Pasini E., Tosatto S.C., Striano P. LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Hum. Mutat. 2009, 30:530-536.
58. Noebels J.L. The biology of epilepsy genes. Annu. Rev. Neurosci. 2003, 26:599-625.
59. Ohkawa T., Fukata Y., Yamasaki M., Miyazaki T., Yokoi N., Takashima H., Watanabe M., Watanabe O., Fukata M. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J. Neurosci. 2013, 33:18161-18174.
60. Ottman R., Risch N., Hauser W.A., Pedley T.A., Lee J.H., Barker-Cummings C., Lustenberger A., Nagle K.J., Lee K.S., Scheuer M.L., et al. Localization of a gene for partial epilepsy to chromosome 10q. Nat. Genet. 1995, 10:56-60.
61. Ottman R., Winawer M.R., Kalachikov S., Barker-Cummings C., Gilliam T.C., Pedley T.A., Hauser W.A. LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 2004, 62:1120-1126.
62. Owuor K., Harel N.Y., Englot D.J., Hisama F., Blumenfeld H., Strittmatter S.M. LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology. Mol. Cell. Neurosci. 2009, 42:448-457.
63. Pisano T., Marini C., Brovedani P., Brizzolara D., Pruna D., Mei D., Moro F., Cianchetti C., Guerrini R. Abnormal phonologic processing in familial lateral temporal lobe epilepsy due to a new LGI1 mutation. Epilepsia 2005, 4:118-123.
64. Poza J.J., Sáenz A., Martínez-Gil A., Cheron N., Cobo A.M., Urtasun M., Martí-Massó J.F., Grid D., Beckmann J.S., Prud'homme J.F., López de Munain A. Autosomal dominant lateral temporal epilepsy: clinical and genetic study of a large Basque pedigree linked to chromosome 10q. Ann. Neurol. 1999, 45:182-188.
65. Ribeiro P.A., Sbragia L., Gilioli R., Langone F., Conte F.F., Lopes-Cendes I. Expression profile of Lgi1 gene in mouse brain during development. J. Mol. Neurosci. 2008, 35:323-329.
66. Sagane K., Hayakawa K., Kai J., Hirohashi T., Takahashi E., Miyamoto N., Ino M., Oki T., Yamazaki K., Nagasu T. Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice. BMC Neurosci. 2005, 6:33.
67. Sagane K., Ishihama Y., Sugimoto H. LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11. Int. J. Biol. Sci. 2008, 4:387-396.
68. Scheel H., Tomiuk S., Hofmann K. A common protein interaction domain links two recently identified epilepsy genes. Hum. Mol. Genet. 2002, 11:1757-1762.
69. Schulte U., Thumfart J.O., Klöcker N., Sailer C.A., Bildl W., Biniossek M., Dehn D., Deller T., Eble S., Abbass K., Wangler T., Knaus H.G., Fakler B. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron 2006, 49:697-706.
70. Senechal K.R., Thaller C., Noebels J.L. ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy. Hum. Mol. Genet. 2005, 14:1613-1620.
71. Seppälä E.H., Jokinen T.S., Fukata M., Fukata Y., Webster M.T., Karlsson E.K., Kilpinen S.K., Steffen F., Dietschi E., Leeb T., Eklund R., Zhao X., Rilstone J.J., Lindblad-Toh K., Minassian B.A., Lohi H. LGI2 truncation causes a remitting focal epilepsy in dogs. PLoS Genet. 2011, 7:e1002194.
72. Silva J., Sharma S., Hughes B., Yu Y.E., Cowell J.K. Homozygous inactivation of the Lgi1 gene results in hypomyelination in the peripheral and central nervous system. J. Neurosci. Res. 2010, 88:3328-3336.
73. Silva J., Wang G., Cowell J.K. Temporal and Spatial expression of the Lgi1 gene during mouse development using a BAC transgenic reporter system. BMC Neurosci. 2011, 12:43.
74. Sirerol-Piquer M.S., Ayerdi-Izquierdo A., Morante-Redolat J.M., Herranz-Pérez V., Favell K., Barker P.A., Pérez-Tur J. The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface. Hum. Mol. Genet. 2006, 15:3436-3445.
75. Smart S.L., Lopantsev V., Zhang C.L., Robbins C.A., Wang H., Chiu S.Y., Schwartzkroin P.A., Messing A., Tempel B.L. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 1998, 20:809-819.
76. Somerville R.P., Chernova O., Liu S., Shoshan Y., Cowell J.K. Identification of the promoter, genomic structure, and mouse ortholog of LGI1. Mamm. Genome 2000, 11:622-627.
77. Staub E., Perez-Tur J., Siebert R., Nobile C., Moschonas N.K., Deloukas P., Hinzmann B. The novel EPTP repeat defines a superfamily of proteins with implications in epileptic disorders. Trends Biochem. Sci. 2002, 27:441-444.
78. Steinlein O.K. Genes and mutations in idiopathic epilepsy. Am. J. Med. Genet. 2001, 106:139-145.
79. Steinlein O.K. Genes and mutations in human idiopathic epilepsy. Brain Dev. 2004, 26:213-218.
80. Striano P., Busolin G., Santulli L., Leonardi E., Coppola A., Vitiello L., Rigon L., Michelucci R., Tosatto S.C., Striano S., Nobile C. Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation. Neurology 2011, 76:1173-1176.
81. Teng Y., Xie X., Walker S., Rempala G., Kozlowski D., Mumm J., Cowell J.K. Knockdown of zebrafish Lgi1a results in abnormal development, brain defects and a seizure-like behavioral phenotype. Hum. Mol. Genet. 2010, 19:4409-4420.
82. Teng Y., Xie X., Walker S., Saxena M., Kozlowski D., Mumm J., Cowell J.K. Loss of zebrafish lgi1b leads to hydrocephalus and sensitization to pentylenetetrazol induced seizure-like behavior. PLoS One 2011, 6:e24596.
83. Tessa C., Michelucci R., Nobile C., Giannelli M., Della Nave R., Testoni S., Bianucci D., Tinuper P., Bisulli F., Sofia V., De Feo M.R., Giallonardo A.T., Tassinari C.A., Mascalchi M. Structural anomaly of left lateral temporal lobe in epilepsy due to mutated LGI1. Neurology 2007, 69:1298-1300.
84. Thomas R., Favell K., Morante-Redolat J., Pool M., Kent C., Wright M., Daignault K., Ferraro G.B., Montcalm S., Durocher Y., Fournier A., Perez-Tur J., Barker P.A. LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition. J. Neurosci. 2010, 30:6607-6612.
85. Winawer M.R., Ottman R., Hauser W.A., Pedley T.A. Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology 2000, 54:2173-2176.
86. Winawer M.R., Martinelli Boneschi F., Barker-Cummings C., Lee J.H., Liu J., Mekios C., Gilliam T.C., Pedley T.A., Hauser W.A., Ottman R. Four new families with autosomal dominant partial epilepsy with auditory features: clinical description and linkage to chromosome 10q24. Epilepsia 2002, 43:60-67.
87. Yu E.Y., Wen L., Silva J., Li Z., Head K., Sossey-Alaoui K., Pao A., Mei L., Cowell J.K. Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability. Hum. Mol. Genet. 2010, 19:1702-1711.
88. Zhou Y.D., Lee S., Jin Z., Wright M., Smith S.E., Anderson M.P. Arrested maturation of excitatory synapses in anobileutosomal dominant lateral temporal lobe epilepsy. Nat. Med. 2009, 15:1208-1214.
89. Zong H., Verhaak R.G., Canoll P. The cellular origin for malignant glioma and prospects for clinical advancements. Expert Rev. Mol. Diagn. 2012, 12:383-394.